Assembly Biosciences (ASMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Sales | 0 | 1,037 | 34,611 | 39,376 | 4,081 |
| Gross Profit | N/A | 1,037 | 34,611 | 39,376 | 4,081 |
| Operating Expenses | 27,258 | 40,679 | 38,630 | 32,797 | 31,775 |
| Operating Income | -27,258 | -39,642 | -4,019 | 6,579 | -27,694 |
| Interest Expense | 0 | 0 | 0 | -691 | 0 |
| Other Income | 58 | 224 | 670 | 0 | 1,039 |
| Pre-tax Income | -27,200 | -39,418 | -3,349 | 7,270 | -26,655 |
| Net Income Continuous | -27,200 | -39,418 | -3,349 | 7,270 | -26,655 |
| Net Income | $-27,200 | $-39,418 | $-3,349 | $7,270 | $-26,655 |
| EPS Basic Total Ops | -8.28 | -13.33 | -1.08 | 2.52 | -9.12 |
| EPS Basic Continuous Ops | -8.23 | -13.28 | -1.13 | 2.47 | -9.12 |
| EPS Diluted Total Ops | -8.28 | -13.09 | -1.08 | 2.28 | -9.12 |
| EPS Diluted Continuous Ops | -8.23 | -13.15 | -1.13 | 2.34 | -9.12 |
| EBITDA(a) | $-27,059 | $-39,261 | $-3,858 | $6,735 | $-27,714 |